Radiosyntheses and in vivo evaluation of carbon-11 PET tracers for PDE10A in the brain of rodent and nonhuman primate

被引:21
作者
Fan, Jinda [1 ]
Zhang, Xiang [1 ]
Li, Junfeng [1 ]
Jin, Hongjun [1 ]
Padakanti, Prashanth K. [1 ]
Jones, Lynne A. [1 ]
Flores, Hubert P. [2 ]
Su, Yi [2 ]
Perlmutter, Joel S. [1 ,2 ]
Tu, Zhude [1 ]
机构
[1] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
PDE10A; Carbon-11; PET imaging; MP-10; CNS; POSITRON-EMISSION-TOMOGRAPHY; STRIATUM-ENRICHED PHOSPHODIESTERASE; MESSENGER-RNA; 10A; INHIBITORS; LOCALIZATION; RADIOLIGAND; DISEASE; CNS;
D O I
10.1016/j.bmc.2014.03.028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The radiosyntheses and in vivo evaluation of four carbon-11 labeled quinoline group-containing radioligands are reported here. Radiolabeling of [C-11]1-4 was achieved by alkylation of their corresponding desmethyl precursors with [C-11]CH3I. Preliminary biodistribution evaluation in Sprague-Dawley rats demonstrated that [11C] 1 and [C-11]2 had high striatal accumulation (at peak time) for [C-11]1 and [C-11]2 were 6.0-fold and 4.5-fold at 60 min, respectively. Following MP-10 pretreatment, striatal uptake in rats of [C-11]1 and [C-11]2 was reduced, suggesting that the tracers bind specifically to PDE10A. MicroPET studies of [C-11]1 and [C-11]2 in nonhuman primates (NHP) also showed good tracer retention in the striatum with rapid clearance from non-target brain regions. Striatal uptake (SUV) of [C-11]1 reached 1.8 at 30 min with a 3.5-fold striatum: cerebellum ratio. In addition, HPLC analysis of solvent extracts from NHP plasma samples suggested that [C-11]1 had a very favorable metabolic stability. Our preclinical investigations suggest that [C-11]1 is a promising candidate for quantification of PDE10A in vivo using PET. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2648 / 2654
页数:7
相关论文
共 29 条
[1]   Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use [J].
Bender, Andrew T. ;
Beavo, Joseph A. .
PHARMACOLOGICAL REVIEWS, 2006, 58 (03) :488-520
[2]   Development of a cell-based assay for screening of phosphodiesterase 10A (PDE10A) inhibitors using a stable recombinant HEK-293 cell line expressing high levels of PDE10A [J].
Bora, Roop Singh ;
Gupta, Dikshi ;
Malik, Renu ;
Chachra, Sonia ;
Sharma, Pratibha ;
Saini, Kulvinder Singh .
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2008, 49 (02) :129-134
[3]   Preclinical Evaluation of 18F-JNJ41510417 as a Radioligand for PET Imaging of Phosphodiesterase-10A in the Brain [J].
Celen, Sofie ;
Koole, Michel ;
De Angelis, Meri ;
Sannen, Ivan ;
Chitneni, Satish K. ;
Alcazar, Jesus ;
Dedeurwaerdere, Stefanie ;
Moechars, Dieder ;
Schmidt, Mark ;
Verbruggen, Alfons ;
Langlois, Xavier ;
Van Laere, Koen ;
Andres, Jose Ignacio ;
Bormans, Guy .
JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (10) :1584-1591
[4]  
Chappie T, 2009, CURR OPIN DRUG DISC, V12, P458
[5]   Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species [J].
Coskran, Timothy M. ;
Morton, Daniel ;
Menniti, Frank S. ;
Adamowicz, Wendy O. ;
Kleiman, Robin J. ;
Ryan, Anne M. ;
Strick, Christine A. ;
Schmidt, Christopher J. ;
Stephenson, Diane T. .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2006, 54 (11) :1205-1213
[6]   Reduced uptake of [18F]FDOPA PET in asymptomatic welders with occupational manganese exposure [J].
Criswell, S. R. ;
Perlmutter, J. S. ;
Videen, T. O. ;
Moerlein, S. M. ;
Flores, H. P. ;
Birke, A. M. ;
Racette, B. A. .
NEUROLOGY, 2011, 76 (15) :1296-1301
[7]   Radiopharmaceutical chemistry for positron emission tomography [J].
Elsinga, PH .
METHODS, 2002, 27 (03) :208-217
[8]   Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A) [J].
Fujishige, K ;
Kotera, J ;
Michibata, H ;
Yuasa, K ;
Takebayashi, S ;
Okumura, K ;
Omori, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (26) :18438-18445
[9]   Phosphodiesterase 10A Inhibitor Activity in Preclinical Models of the Positive, Cognitive, and Negative Symptoms of Schizophrenia [J].
Grauer, Steven M. ;
Pulito, Virginia L. ;
Navarra, Rachel L. ;
Kelly, Michele P. ;
Kelley, Cody ;
Graf, Radka ;
Langen, Barbara ;
Logue, Sheree ;
Brennan, Julie ;
Jiang, Lixin ;
Charych, Erik ;
Egerland, Ute ;
Liu, Feng ;
Marquis, Karen L. ;
Malamas, Michael ;
Hage, Thorsten ;
Comery, Thomas A. ;
Brandon, Nicholas J. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 331 (02) :574-590
[10]   Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms [J].
Hebb, ALO ;
Robertson, HA ;
Denovan-Wright, EM .
NEUROSCIENCE, 2004, 123 (04) :967-981